To study the long-term effects of EXO1 nuclease inactivation on survival and cancer susceptibility, Exo1+/+, Exo1−/− and Exo1DA/DA mouse cohorts were monitored for a period of up to 26 months. The gene discussed is EXO1; the disease is cancer.